The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 6-U.S. tightens Ebola monitoring for West African visitors

Wed, 22nd Oct 2014 21:41

(Adds Obama comments, paragraphs 2, 14-17)

By Bill Berkrot

NEW YORK, Oct 22 (Reuters) - U.S. health officials imposedfresh constraints on Wednesday on people entering the countryfrom three countries at the center of West Africa's Ebolaepidemic, mandating that they report their temperature daily andstay in touch with health authorities.

President Barack Obama expressed cautious optimism about thesituation in the United States after meeting with his Ebolaresponse coordinator, Ron Klain, and other top officials onKlain's first day on the job since being named on Friday.

The U.S. Centers for Disease Control and Prevention's newrestrictions on travelers arriving from Liberia, Sierra Leoneand Guinea marked the latest precautions put in place by theObama administration to stop the spread of the virus. The stepsstopped short of a ban on travelers from those countries demanded by some lawmakers.

The CDC said that, beginning on Monday, travelers from thosecountries will be directed to check in with health officialsevery day and report their temperatures and any Ebola symptomsfor 21 days, the period of incubation for the virus.

The travelers will be required to provide emails, phonenumbers and addresses for themselves and for a friend orrelative in the United States covering the 21 days, and theinformation will be shared with local health authorities.

The travelers also will be required to coordinate with localpublic health officials if they intend to travel within theUnited States. If a traveler does not report in, local healthofficials will take immediate steps to find the person.

CDC Director Dr. Tom Frieden told reporters the activemonitoring program will remain in place until the outbreak inWest Africa is over. The U.N. World Health Organization's latestfigures on Wednesday showed at least 4,877 people out of 9,936cases have died in the outbreak, the worst on record.

"These new measures I'm announcing today will giveadditional levels of safety so that people who develop symptomsof Ebola are isolated early in the course of their illness,"Frieden said. "That will reduce the chance that Ebola willspread from an ill person through close contact and tohealthcare workers."

Beginning Wednesday, travelers from Liberia, Sierra Leone orGuinea were being funneled through one of five major U.S.airports conducting increased screening for the virus.

There are no direct commercial flights to the United Statesfrom those countries, but officials say about 150 travelers aday arrive in the United States on trips that originated there.

Six states account for nearly 70 percent of all travelersarriving from the affected countries: New York, Pennsylvania,Maryland, Virginia, New Jersey and Georgia. The new monitoringwill begin in those states first and will be expanded to otherstates.

The CDC said the monitoring program affects anyone comingback from the region, including CDC employees and journalists.It said when affected travelers enter one of the five airportsthey will receive a care kit that contains a tracking log, apictorial description of symptoms, a thermometer, instructionson how to monitor their temperature and information on what todo if they experience symptoms.

Three Ebola cases have been diagnosed in the United States:Thomas Eric Duncan, a Liberian who fell ill after flying to theUnited States in September, and two nurses, Nina Pham and AmberVinson, who treated him at Texas Health Presbyterian Hospital inDallas. Duncan died on Oct. 8, while the nurses are beingtreated at other facilities.

OBAMA SEES PROGRESS

Speaking in the White House Oval Office with Klain sittingon a couch beside him, Obama said the CDC would continue to putin place further measures to prevent the spread of Ebola asneeded.

"A number of things make us cautiously more optimistic aboutthe situation here in the United States," Obama said, notingthat dozens of people who interacted with Duncan did not getEbola.

Obama said officials were working to ensure that problemsthat arose with Ebola protocols at the Dallas hospital do notoccur again. He expressed confidence that any further Ebolapatients would get first-class treatment and said officialswould make sure hospitals are prepared and would take the rightprecautions.

On the situation in West Africa, Obama said, "We're alreadystarting to see some very modest signs of progress in Liberia.We're concerned about some spike in cases in Guinea."

Human testing of a second "investigational" Ebola vaccinehas begun at the U.S. National Institutes of Health's ClinicalCenter in Maryland, officials said.

The vaccine was developed at the Public Health Agency ofCanada's National Microbiology Laboratory and licensed toNewLink Genetics Corp through its wholly ownedsubsidiary BioProtection Systems, both based in Ames, Iowa, theNIH said.

Testing on a first potential vaccine began last month, andinitial data was expected by the end of the year.

NBC freelance cameraman Ashoka Mukpo, an American whocontracted Ebola while working in West Africa, is free of thevirus and was discharged on Wednesday from a special unit atNebraska Medical Center in Omaha, the hospital said.

"After enduring weeks where it was unclear whether I wouldsurvive, I'm walking out of the hospital on my own power, freefrom Ebola," Mukpo said in a statement.

"I feel profoundly blessed to be alive, and in the samebreath aware of the global inequalities that allowed me to beflown to an American hospital when so many Liberians die alonewith minimal care," Mukpo added.

The 1-year-old King Charles Spaniel belonging to Pham hastested free of the virus and will remain in isolation for theremainder of the 21-day monitoring period, the city of Dallassaid. (Additional reporting by Ben Hirschler in London, Will Dunhamand Susan Heavey in Washington, Barbara Goldberg in New York,Julie Steenhuysen in Chicago and David Bailey in Minneapolis;Writing by Will Dunham; Editing by Michele Gershberg, GrantMcCool and Jonathan Oatis)

More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.